Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Mar;62(3):208–214. doi: 10.1136/ard.62.3.208

An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis

L Skoldstam 1, L Hagfors 1, G Johansson 1
PMCID: PMC1754463  PMID: 12594104

Abstract

Objective: To investigate the efficacy of a Mediterranean diet (MD) versus an ordinary Western diet for suppression of disease activity in patients with rheumatoid arthritis (RA).

Methods: Patients with well controlled, although active RA of at least two years' duration, who were receiving stable pharmacological treatment, were invited to participate. All patients were randomly allocated to the MD or the control diet (CD). To achieve good compliance with prescribed diets all patients were for the first three weeks served the MD or the CD, respectively, for lunch and dinner at the outpatient clinic's canteen. Clinical examinations were performed at baseline, and again in the 3rd, 6th, and 12th week. A composite disease activity index (DAS28), a physical function index (Health Assessment Questionnaire (HAQ)), a health survey of quality of life (Short Form-36 (SF-36)), and the daily consumption of non-steroidal anti-inflammatory drugs were used as primary efficacy variables.

Results: From baseline to the end of the study the patients in the MD group (n=26) showed a decrease in DAS28 of 0.56 (p<0.001), in HAQ of 0.15 (p=0.020), and in two dimensions of the SF-36 Health Survey: an increase in "vitality" of 11.3 (p=0.018) and a decrease in "compared with one year earlier" of 0.6 (p=0.016). For the control patients (n=25) no significant change was seen at the end of the study. This difference between the two treatment groups was notable only in the second half of the trial.

Conclusion: The results indicate that patients with RA, by adjusting to a Mediterranean diet, did obtain a reduction in inflammatory activity, an increase in physical function, and improved vitality.

Full Text

The Full Text of this article is available as a PDF (195.4 KB).

Figure 1.

Figure 1

Open in a new tab

Patient's global assessment of disease activity by means of a VAS (0–100 mm) at baseline and weeks 3, 6, and 12. The results are presented in relative terms, where the baseline value is set to zero, as mean values with 95% confidence intervals.

Figure 2.

Figure 2

Open in a new tab

Disease activity (DAS28 score) at baseline and at weeks 6 and 12. The results are presented in relative terms, where the baseline value is set to zero, as mean values with 95% confidence intervals.

Figure 3.

Figure 3

Open in a new tab

Distributions of change in DAS28 score. A change in DAS28 score >0.6 is considered to be a change of clinical significance.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Darlington L. G., Ramsey N. W., Mansfield J. R. Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet. 1986 Feb 1;1(8475):236–238. doi: 10.1016/s0140-6736(86)90774-9. [DOI] [PubMed] [Google Scholar]
  2. Dellhag B., Bjelle A. A Grip Ability Test for use in rheumatology practice. J Rheumatol. 1995 Aug;22(8):1559–1565. [PubMed] [Google Scholar]
  3. Drosos A. A., Alamanos I., Voulgari P. V., Psychos D. N., Katsaraki A., Papadopoulos I., Dimou G., Siozos C. Epidemiology of adult rheumatoid arthritis in northwest Greece 1987-1995. J Rheumatol. 1997 Nov;24(11):2129–2133. [PubMed] [Google Scholar]
  4. Eberhardt K. B., Svensson B., Mortiz U. Functional assessment of early rheumatoid arthritis. Br J Rheumatol. 1988 Oct;27(5):364–371. doi: 10.1093/rheumatology/27.5.364. [DOI] [PubMed] [Google Scholar]
  5. Ekdahl C., Eberhardt K., Andersson S. I., Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988;17(4):263–271. doi: 10.3109/03009748809098795. [DOI] [PubMed] [Google Scholar]
  6. Emery P., Luqmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol. 1993 Jun;32 (Suppl 3):3–8. doi: 10.1093/rheumatology/32.suppl_3.3. [DOI] [PubMed] [Google Scholar]
  7. Grimble R. F. Nutritional modulation of cytokine biology. Nutrition. 1998 Jul-Aug;14(7-8):634–640. doi: 10.1016/s0899-9007(98)00010-0. [DOI] [PubMed] [Google Scholar]
  8. Hansen G. V., Nielsen L., Kluger E., Thysen M., Emmertsen H., Stengaard-Pedersen K., Hansen E. L., Unger B., Andersen P. W. Nutritional status of Danish rheumatoid arthritis patients and effects of a diet adjusted in energy intake, fish-meal, and antioxidants. Scand J Rheumatol. 1996;25(5):325–330. doi: 10.3109/03009749609104066. [DOI] [PubMed] [Google Scholar]
  9. Kaptchuk T. J. Powerful placebo: the dark side of the randomised controlled trial. Lancet. 1998 Jun 6;351(9117):1722–1725. doi: 10.1016/S0140-6736(97)10111-8. [DOI] [PubMed] [Google Scholar]
  10. Kjeldsen-Kragh J., Haugen M., Borchgrevink C. F., Laerum E., Eek M., Mowinkel P., Hovi K., Førre O. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991 Oct 12;338(8772):899–902. doi: 10.1016/0140-6736(91)91770-u. [DOI] [PubMed] [Google Scholar]
  11. Kromhout D., Keys A., Aravanis C., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S., Pekkarinen M. Food consumption patterns in the 1960s in seven countries. Am J Clin Nutr. 1989 May;49(5):889–894. doi: 10.1093/ajcn/49.5.889. [DOI] [PubMed] [Google Scholar]
  12. Linos A., Kaklamani V. G., Kaklamani E., Koumantaki Y., Giziaki E., Papazoglou S., Mantzoros C. S. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables? Am J Clin Nutr. 1999 Dec;70(6):1077–1082. doi: 10.1093/ajcn/70.6.1077. [DOI] [PubMed] [Google Scholar]
  13. Linos A., Kaklamanis E., Kontomerkos A., Koumantaki Y., Gazi S., Vaiopoulos G., Tsokos G. C., Kaklamanis P. The effect of olive oil and fish consumption on rheumatoid arthritis--a case control study. Scand J Rheumatol. 1991;20(6):419–426. doi: 10.3109/03009749109096821. [DOI] [PubMed] [Google Scholar]
  14. Morgan S. L., Anderson A. M., Hood S. M., Matthews P. A., Lee J. Y., Alarcón G. S. Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis. Arthritis Care Res. 1997 Feb;10(1):9–17. doi: 10.1002/art.1790100103. [DOI] [PubMed] [Google Scholar]
  15. Recht L., Helin P., Rasmussen J. O., Jacobsen J., Lithman T., Scherstén B. Hand handicap and rheumatoid arthritis in a fish-eating society (the Faroe Islands). J Intern Med. 1990 Jan;227(1):49–55. doi: 10.1111/j.1365-2796.1990.tb00118.x. [DOI] [PubMed] [Google Scholar]
  16. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  17. Roubenoff R., Roubenoff R. A., Cannon J. G., Kehayias J. J., Zhuang H., Dawson-Hughes B., Dinarello C. A., Rosenberg I. H. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994 Jun;93(6):2379–2386. doi: 10.1172/JCI117244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shapiro J. A., Koepsell T. D., Voigt L. F., Dugowson C. E., Kestin M., Nelson J. L. Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology. 1996 May;7(3):256–263. doi: 10.1097/00001648-199605000-00007. [DOI] [PubMed] [Google Scholar]
  19. Sköldstam L. Fasting and vegan diet in rheumatoid arthritis. Scand J Rheumatol. 1986;15(2):219–221. doi: 10.3109/03009748609102091. [DOI] [PubMed] [Google Scholar]
  20. Sköldstam L., Larsson L., Lindström F. D. Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol. 1979;8(4):249–255. doi: 10.3109/03009747909114631. [DOI] [PubMed] [Google Scholar]
  21. Sullivan M., Karlsson J., Ware J. E., Jr The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995 Nov;41(10):1349–1358. doi: 10.1016/0277-9536(95)00125-q. [DOI] [PubMed] [Google Scholar]
  22. Symmons D. P., Bankhead C. R., Harrison B. J., Brennan P., Barrett E. M., Scott D. G., Silman A. J. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum. 1997 Nov;40(11):1955–1961. doi: 10.1002/art.1780401106. [DOI] [PubMed] [Google Scholar]
  23. Wallberg-Jonsson S., Ohman M. L., Dahlqvist S. R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997 Mar;24(3):445–451. [PubMed] [Google Scholar]
  24. de Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J. L., Monjaud I., Guidollet J., Touboul P., Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994 Jun 11;343(8911):1454–1459. doi: 10.1016/s0140-6736(94)92580-1. [DOI] [PubMed] [Google Scholar]
  25. van Riel P. L., van Gestel A. M. Clinical outcome measures in rheumatoid arthritis. Ann Rheum Dis. 2000 Nov;59 (Suppl 1):i28–i31. doi: 10.1136/ard.59.suppl_1.i28. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES